Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-10-01
2011-11-22
Ouspenski, Ilia (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
08062852
ABSTRACT:
Disclosed herein are methods of treatment of autoimmune diseases such as systemic lupus erythematosus (SLE) as well as clinical assays for detection of autoimmune disease activity in patients utilizing the involving a PD1 ligand.
REFERENCES:
patent: 6808710 (2004-10-01), Wood et al.
Albert et al, Immature dendritic cells phagocytose apoptotic cells via αv β5 and CD36, and cross-present antigens to cytotoxic T lymphocytes, J Exp Med, (1998), 188(7):1359-1368.
Avarado-Sánchez et al, Regulatory T cells in patients with systemic lupus erythematosus, J Aut, (2006), 27:110-118.
Blanco et al, Induction of dendritic cell differentiation by INF-alpha in systemic lupus erythematosus, Science, (2001), 294:1540-1543.
Brown et al, Blockade of Programmed Death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production, The Journal of Immunology, (2003), 170:1257-1266.
Butte et al, PD-L1 interacts specifically with B7-1 to inhibit T cell proliferation, Immunity, (2007), 27(1):111-112.
Carter et al, PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis, Journal of Neuroimmunology, (2007), 182:124-134.
Chen et al, Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells, Immunobiology, (2007), 212:159-165.
Chen et al, Increased Apoptosis of Peripheral Blood Lymphocytes and Its Association With Interleukin-18 in Patents With Active Untreated Adult-Onset Still's Disease, Arthritis & Rhematism, (2007), 57(8):1530-1538.
Decker et al, Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus, Rheumatology, (2006), 45:1087-1095.
Ding et al, Aberrant Phenotype and Function of Myeloid Dendritic Cells in Systemic Lupus Erythematosus, Journal of Immunology, (2006), 177:5878-5889.
Ding et al, B7H1-Ig Fusion Protein Activates the CD4+ IFN-γ Receptor Type 1 T Regulatory Subset Through IFN-γ-Secreting Th1 Cells, The Journal of Immunology, (2006), 177:3606-3614.
Dong et al, B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion, Nature America Inc., (1999), 5(12):1365.
Dong et al, Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion, Nature Medicine, (2002), 8(8):793.
Feng et al, Association of Increased Interferon-Inducible Gene Expression With Disease Activity and Lupus Nephritis in Patients With Systemic Lupus Erythematosus, Arthritis & Rheumatism, (2006), 54(9):2951-2952.
Ferreiros-Vidal et al, Association of PDCD1 With Susceptibility to Systemic Lupus Erythematosus, Arthritis & Reumatism, (2004), 50(8):2590-2597.
Fife et al, Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway, JEM, (2006), 203(12):2737-2747.
Fiore et al, Immature myeloid and plasmacytoid dendritic cells inflitrate renal tubulointerstitium in patients with lupus nephristis, Molecular Immunology, (2008), 45:259-265.
Freeman et al, Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation, J Exp Med, (2000), 192(7):1027-1034.
Fukushima et al, Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice, Br J Opthalmol, (2006), 90:1040-1045.
Geng et al, B7-H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels, Journal of Viral Hepatitis, (2006), 13:725-733.
Golden-Mason et al, Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specifric CD8+ T Cells Associated with Reversible Immune Dysfunction, Journal of Virology, (2007), 249-9258.
He et al, Programmed death-1 ligands-transfected dendritic cells loaded with glutamic acid decarboxylase 65 (GAD65) inhibit both the alloresponse and the GAD65-reactive lymphocyte response, Clinical and Experimental Immunology, (2007), 151:86-93.
Hirata et al, Prevention of Experimental Automimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with Trail or Programmed Death-1 Ligand, The Journal of Immunology, (2005).
Hochberg et al, Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate: comment on the artcle by Helfgott and Kieval, Arthritis & Rheumatism, (1997), 40(9): 1725.
Karni et al, Innate Immunity in Multiple Sclerosis: Myeloid Dendritic Cells in Secondary Progressive Multiple Sclerosis Are Activated and Drive a Proinflammatory Immune Response, J Immuno, (2006), 177:4196-4202.
Keir et al, Tissue expression of PD-L1 mediates peripheral T cell tolerance, JEM, (2006), 203(4):883-895.
Kim et al, High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals, Journal of Leukocyte Biology, (2006), 79:686.
Kitazawa et al, Involvement of the Programmed Death-1/Programmed Death-1 Ligand Pathway in CD4+CD25+Regulatory T-Cell Activity to Suppress Alloimmune Responses, Transplantation, (2007), 83:774-782.
Krishnan et al, Increased Caspase-3 Expression and Activity Contribute to Reduced CD3ζ Expression in Systemic Lupus Erythematosus T Cells, The Journal of Immunology, (2005), 175:3417-3423.
Latchman et al, PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells, PNAS, (2004), 101(29):10691-10696.
Latchman et al, PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nature Immunology, (2001), 2(3):261-268.
Liang et al, Regulation of PD-1, PD-I1, and PD-L2 expression during normal and autoimmune responses, Eur J Immunol, (2003), 33:2706-2716.
Liu et al, Differential Expression and Modulation of Costimulatory Molecules CD80 and CD86 on Monocytes from Patients with Systemic Lupus Erythematosus, Sc and J Immunol, (1999), 49:82-87.
Martin-Orozco et al, Cutting Edge: Programed Death(PD) Ligand-1/PD-1 Interaction Is Required for CD8+ T Cell Tolerance to Tissue Antigens, The Journal of Immunology, (2006), 177:8291-8295.
Mosca et al, The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus, Lupus, (2000), 9:445-450.
Nishimura et al, Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor, Immunity, (1999), 11:141-151.
Probst et al, Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4, Nature Immunology, (2005), 6(3):280.
Prokunina et al, A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans, Nature Genetics, (2002), 32:666.
Sakane et al, Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus, Proc Natl Acad Sci, (1978), 75(7):3464-3468.
Scheinecker et al, Initiation of the Autologous Mixed Lymphocyte Reaction Requires the Expression of Costimulatory Molecules B7-1 and B7-2 on Human Peripheral Blood Dendritic Cells, The Journal of Immunology, (1998), 161:3966-3973.
Sharpe et al, The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection, Nature Immunology, (2007), 8(3):239.
Thorburn et al, Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort, Genes Immun, (2007), 8(4):279-287.
Trabattoni et al, B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression, Blood, (2002), 101:2514-2520.
Tsutsumi et al, Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes, Diabet Med, (2006), 23:1145-1150.
Valencia et al, Deficient DC4+DC25 high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus, J. Immunol., 2007, 178:2579-2588.
Mozaffarian Neelufar
Stevens Anne M.
Foley & Lardner LLP
Ouspenski Ilia
The Children's Hospital and Regional Medical Center
LandOfFree
Detection and treatment of autoimmune disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection and treatment of autoimmune disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and treatment of autoimmune disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280907